Potentiation of beta-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2004-01-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BBAGEN.2003.11.005PMID 14738998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease

  2004cited by this paper
• An investigation into the mechanisms mediating plasma lipoprotein‐potentiated β‐amyloid fibrillogenesis

  2002cited by this paper
• Measures of oxidative stress in heterozygous familial hypercholesterolaemia.

  2001cited by this paper
• Platelet secretion of beta-amyloid is increased in hypercholesterolaemia.

  2001cited by this paper
• Platelet secretion of β-amyloid is increased in hypercholesterolaemia

  2001cited by this paper
• Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.

  2000cited by this paper
• Modes of regulation of ubiquitin‐mediated protein degradation

  2000cited by this paper
• Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.

  2000cited by this paper
• Proteasome Inhibitors Induce Cytochrome c–Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons

  2000cited by this paper
• Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

  2000cited by this paper
• Role of the proteasome in Alzheimer's disease.

  2000cited by this paper
• Oxidized LDLs alter the activity of the ubiquitin‐proteasome pathway: potential role in oxidized LDL‐induced apoptosis

  2000cited by this paper
• Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage

  1999cited by this paper
• Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver.

  1999cited by this paper
• Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets.

  1998cited by this paper
• Alzheimer's beta-amyloid vasoactivity: identification of a novel beta-amyloid conformational intermediate.

  1998cited by this paper
• Alzheimer's β‐amyloid vasoactivity: identification of a novel β‐amyloid conformational intermediate

  1998cited by this paper
• β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

  1998cited by this paper
• Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

  1998cited by this paper
• beta-amyloid-induced endothelial necrosis and inhibition of nitric oxide production.

  1997cited by this paper
• Pathways of ubiquitin conjugation

  1997cited by this paper
• Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?

  1997cited by this paper
• Stimulated release of the beta-amyloid protein of Alzheimer's disease by normal human platelets.

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• Targeting of substrates to the 26S proteasome

  1997cited by this paper
• Amyloid β‐Peptide Induces Cell Monolayer Albumin Permeability, Impairs Glucose Transport, and Induces Apoptosis in Vascular Endothelial Cells

  1997cited by this paper
• Cerebrovascular endothelial dysfunction mediated by beta-amyloid.

  1997cited by this paper
• β-Amyloid-Induced Endothelial Necrosis and Inhibition of Nitric Oxide Production☆

  1997cited by this paper
• Cerebrovascular endothelial dysfunction mediated by β‐amyloid

  1997cited by this paper
• Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

  1997cited by this paper
• Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity.

  1997cited by this paper
• Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs

  1996cited by this paper
• β-Amyloid-mediated vasoactivity and vascular endothelial damage

  1996cited by this paper
• Amyloid β-Peptide Is Transported on Lipoproteins and Albumin in Human Plasma*

  1996cited by this paper
• Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs.

  1996cited by this paper
• beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

  1996cited by this paper
• Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro(*)

  1995cited by this paper
• Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells

  1995cited by this paper
• Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

  1995cited by this paper
• Platelets are the primary source of amyloid beta-peptide in human blood.

  1995cited by this paper
• Characterization of Pharmacologically Active Anti‐Peptide Antibodies Directed Against the First and Second Extracellular Loops of the Serotonin 5‐HT1A Receptor

  1995cited by this paper
• Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol

  1994cited by this paper
• Detection of conjugated dienes by second derivative ultraviolet spectrophotometry.

  1994cited by this paper
• A New Inhibitor of the Chymotrypsin‐Like Activity of the Multicatalytic Proteinase Complex (20S Proteasome) Induces Accumulation of Ubiquitin‐Protein Conjugates in a Neuronal Cell

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Amyloid deposition as the central event in the aetiology of Alzheimer's disease.

  1991cited by this paper
• Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

  1989cited by this paper
• Toxicity of oxidized low‐density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Oxygen-mediated heterogeneity of apo-low-density lipoprotein.

  1978cited by this paper
• Lowry determination of protein in the presence of Triton X-100.

  1975cited by this paper
• Practical methods for plasma lipoprotein analysis.

  1968cited by this paper
• SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS.

  1963cited by this paper

• Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in Humans

  2022cites this paper
• Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery.

  2010cites this paper
• Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers

  2008cites this paper
• Native and oxidized low-density lipoproteins modulate the vasoactive actions of soluble beta-amyloid peptides in rat aorta.

  2007cites this paper
• Beta-amyloid (Abeta40, Abeta42) binding to modified LDL accelerates macrophage foam cell formation.

  2007cites this paper
• Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia * * Supported by

  2007cites this paper
• β-Amyloid (Aβ40, Aβ42) binding to modified LDL accelerates macrophage foam cell formation

  2007cites this paper
• Influence of E-LDL and Ox-LDL on the metabolism of ApoE, cholesterol, sphingolipids and glycosphingolipids as well as on the raft-composition in human macrophages

  2006cites this paper
• Changes in the lipid composition of blood plasma and liver in rats induced by severe psychic trauma

  2006cites this paper
• β-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins

  2004cites this paper
• Exaggerated polymerisation of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Abeta preparations that are ineffective in promoting ADP-induced platelet aggregation.

  2004cites this paper